AZD4205, a potent, GI tract-enriched, JAK1-selective inhibitor for treatment of inflammatory bowel disease (IBD)

Wang, M; John, T; Zhang, L; Zhu, L; Xu, Y; Chen, K; Han, S; Li, J; Wang, F; Deceneux, C; Behren, A; Yang, Z

JOURNAL OF CROHNS & COLITIS, 2019; 13 (): S36